Hormone receptor positive breast cancer represents the most common type of breast cancer, affecting the majority of people diagnosed with this disease. Understanding how hormones like estrogen and progesterone can fuel cancer growth opens the door to targeted treatments that can significantly improve outcomes and quality of life for patients.

Understanding Hormone Receptor Positive Breast Cancer

When doctors diagnose breast cancer, they don’t just identify the presence of cancer cells—they also look closely at what makes those cells grow. Breast cancer cells can contain special proteins on their surface called hormone receptors, which are tiny structures that receive messages from hormones traveling through the body. Think of these receptors as locks, and hormones as keys that fit into them. When the hormone “key” connects with the receptor “lock,” it tells the cancer cell to divide and multiply.^[1]

Hormone receptor positive breast cancer, often written as HR-positive or HR+, means that the cancer cells have receptors that respond to either estrogen, progesterone, or both of these hormones. When these hormones attach to the receptors on cancer cells, they trigger changes that cause the tumor to grow larger and the cancer to spread.^[3] This type of cancer is fundamentally different from hormone receptor negative breast cancer, where the cells don’t have these receptors and therefore don’t rely on hormones to grow.

The two main types of hormone receptors found in breast cancer are estrogen receptors (ER) and progesterone receptors (PR). If your tumor has estrogen receptors, it’s called estrogen receptor positive or ER-positive. If it has progesterone receptors, it’s progesterone receptor positive or PR-positive. Many breast cancers are positive for both types of receptors, written as ER+/PR+. Less commonly, a cancer might be positive for only one type—for example, ER+/PR- or, very rarely, ER-/PR+.^[3]

There’s also a category called triple-positive breast cancer, which means the tumor is positive for both hormone receptors (ER+ and PR+) and also expresses another protein called HER2 (human epidermal growth factor 2). Each of these combinations may respond differently to treatments, which is why testing is so important.^[3]

How Common Is Hormone Receptor Positive Breast Cancer?

Hormone receptor positive breast cancer is remarkably common. Between 70% and 80% of all breast cancer cases are driven by the body’s natural hormones, estrogen and progesterone.^[3] More specifically, approximately 67% to 80% of breast cancers in women are estrogen receptor positive, and most ER-positive breast cancers are also PR-positive.^[2]

This type of breast cancer affects not just women but also men, though breast cancer in men is much rarer overall. Approximately 90% of breast cancers in men are ER-positive, and about 80% are PR-positive.^[2] The high prevalence of hormone receptor positive breast cancer means that most people diagnosed with breast cancer will have a tumor that responds to hormones, which is actually good news—it means they can benefit from hormone-blocking treatments.

About 80% of breast cancers are checked for hormone status and found to have at least one type of hormone receptor.^[6] The consistency of these numbers across different populations underscores how fundamental hormone-driven growth is to the biology of breast cancer.

What Causes Hormone Receptor Positive Breast Cancer?

To understand what causes hormone receptor positive breast cancer, it helps to know a bit about how hormones work in the body. Hormones are chemical messengers produced in various organs that control growth, reproduction, and many other functions throughout your body.^[1] Estrogen and progesterone, the hormones most relevant to breast cancer, are produced primarily by the ovaries in women who are still having menstrual periods (premenopausal women). After menopause, these hormones are still produced in smaller amounts by other tissues including fat and skin, in both women and men.^[2]

Estrogen plays an important role in the female reproductive system, promotes the development and maintenance of female sex characteristics, and supports the growth of long bones. Progesterone is involved in the menstrual cycle and pregnancy.^[2] Both hormones also promote the growth of some breast cells as part of normal, healthy breast development.

The problem begins when breast cells become cancerous and still retain these hormone receptors. When breast cancer cells contain hormone receptors, they become activated when hormones bind to them. The activated receptors cause changes in how specific genes are expressed, which can stimulate cell growth.^[2] Essentially, the normal process that helps healthy breast cells grow and function becomes hijacked by cancer cells, causing them to multiply out of control.

ER-positive breast cancer occurs when estrogen connects with proteins inside cancer cells, causing the cells to grow. This can also happen when both estrogen and progesterone connect with proteins inside cancer cells.^[9] The hormones travel through the bloodstream, reach the breast tissue, and when they encounter cancer cells with matching receptors, they deliver a signal that essentially says “grow and divide.”

Risk Factors for Hormone Receptor Positive Breast Cancer

Certain factors can increase a person’s risk of developing hormone receptor positive breast cancer, and many of these are related to how much exposure someone has had to estrogen and progesterone over their lifetime. For women, the overarching risk factor is long-term exposure to estrogen.^[9] The more years a woman’s body is exposed to these hormones, the more opportunity there is for hormone-driven cancers to develop.

Several life stages and circumstances affect hormone exposure in women. Having early periods means starting estrogen exposure at a younger age, which extends the total years of exposure over a lifetime. Similarly, having late menopause means the body continues producing significant amounts of estrogen and progesterone for more years than average.^[9] Women who give birth later in life or never have children may have slightly different hormone patterns than those who have children earlier, which can affect risk.

Taking hormone therapy for menopause symptoms, which provides supplemental estrogen and sometimes progesterone to relieve hot flashes and other symptoms, can also influence breast cancer risk. This is different from hormone therapy used to treat breast cancer—menopausal hormone therapy actually increases hormone levels in the body, which is the opposite of what’s needed for someone with HR-positive breast cancer.^[2]

For men, the risk factors are linked to situations where they have more estrogen and less testosterone than usual, creating a hormonal imbalance. Conditions such as obesity, diabetes, and cirrhosis of the liver can all affect the balance of hormones in the male body and potentially increase breast cancer risk.^[9]

Symptoms of Hormone Receptor Positive Breast Cancer

People with hormone receptor positive breast cancer typically experience the same symptoms as those with other types of breast cancer. The symptoms themselves don’t reveal whether the cancer is hormone-driven or not—that information comes from laboratory testing. However, recognizing these symptoms early and seeking medical attention is crucial for any type of breast cancer.

One of the most common signs is a change in the size, shape, or contour of your breast. You might notice a mass or lump, which could feel as small as a pea, or a thickening in or near your breast or in your underarm area that persists through your menstrual cycle (if you’re still menstruating).^[9] Not all lumps are cancer, but any new or changing lump should be evaluated by a healthcare provider.

Changes in the appearance of the breast skin or nipple are also important warning signs. The skin might look dimpled or puckered, similar to the texture of an orange peel. It might appear scaly, inflamed, red, or darker than other parts of the breast. You might feel a marble-like hardened area under the skin.^[9] Some people notice discharge from the nipple that is clear or blood-stained, which is different from milk production.

It’s worth noting that breast pain alone is not typically a definitive sign of breast cancer. However, any persistent or unusual changes in your breasts should be discussed with your doctor. Early detection significantly improves treatment outcomes, regardless of the breast cancer subtype.

How Doctors Diagnose and Test for Hormone Receptor Status

When breast cancer is suspected, doctors perform a biopsy, which means they remove a small sample of tissue to be examined under a microscope.^[1] This tissue can be obtained during a biopsy procedure before surgery, or after the cancer has been surgically removed. The samples are sent to a laboratory where a medical pathologist performs specialized tests.

The test used to determine hormone receptor status is typically done using a technique called immunohistochemistry (IHC), which measures how many hormone receptors are present on the cancer cells. The results are usually reported as a percentage—higher percentages mean the tumor is more responsive to hormones.^[3] This percentage tells doctors how strongly the cancer depends on hormones to grow.

If the tumor cells contain estrogen receptors, the cancer is called estrogen receptor positive (ER-positive), estrogen sensitive, or estrogen responsive. Similarly, if the tumor cells contain progesterone receptors, the cancer is called progesterone receptor positive (PR-positive or PgR-positive). When breast tumors contain estrogen and/or progesterone receptors, they’re sometimes collectively called hormone receptor positive (HR-positive).^[2]

It’s important to know that hormone receptor status can sometimes change. If breast cancer returns or spreads to other parts of the body (a process called metastasis), the cancer cells in the new location might have different characteristics than the original tumor. For example, if the first tumor was treated with hormone therapies, a cancer that has returned may become resistant to that therapy. In other cases, a tumor may undergo changes or mutations that alter its hormone receptor status.^[3] This is why doctors may recommend retesting the cancer’s characteristics if it comes back or progresses.

Prevention and Risk Reduction

While we cannot completely prevent breast cancer, there are evidence-based lifestyle changes that may help reduce risk, including the risk of hormone receptor positive breast cancer. These same strategies are often recommended for people who have already been treated for breast cancer to reduce their risk of recurrence (the cancer coming back).

The World Cancer Research Fund recommends that people who have had breast cancer follow advice to reduce their risk of recurrence, including eating a healthy diet that is high in fiber and low in saturated fats, being physically active, maintaining a healthy weight, and limiting alcohol.^[18] These recommendations are based on research showing links between lifestyle factors and breast cancer outcomes.

Maintaining a healthy weight is particularly important. Women who gain weight during or after treatment for breast cancer have consistently been shown to be at higher risk of breast cancer-related death. Similarly, women who are overweight or obese at the time of diagnosis tend to have a poorer prognosis.^[16] The mechanisms behind this involve complex interactions between body weight and hormones—excess body fat can produce additional estrogen, increase insulin-like growth factors, and create inflammation in the body.

Physical activity provides multiple benefits. Research shows that exercise is a key component for extending cancer survivorship and managing side effects of treatment. It can range from vigorous aerobic activity like running to gentler options like yoga, tai chi, strength training, or walking.^[17] Exercise plans should be supervised by doctors based on each patient’s physical fitness level at the start of treatment.

Diet matters, too. There is some evidence that eating foods high in fiber may reduce the risk of breast cancer recurrence, though more research is needed. High-fiber foods include wholegrain products like brown rice and oats, pulses such as lentils and beans, starchy vegetables like potatoes (with skins), and fruits and vegetables.^[18] Conversely, there is some evidence that saturated fat may increase recurrence risk, so limiting fatty cuts of meat, processed meats, full-fat dairy products, and foods high in saturated fats like butter, chocolate, and baked goods may be beneficial.

Regarding alcohol, limiting consumption is advisable, as alcohol has been linked to increased breast cancer risk and potentially to recurrence. While the research continues to evolve, keeping alcohol intake low or avoiding it altogether is a prudent choice for those concerned about hormone receptor positive breast cancer.

How Hormone Receptor Positive Breast Cancer Affects the Body

Understanding the pathophysiology—the changes in normal body functions caused by disease—helps explain how hormone receptor positive breast cancer behaves differently from other cancer types. At the cellular level, the presence of hormone receptors fundamentally changes how cancer cells respond to the body’s natural hormone environment.

In healthy breast tissue, hormone receptors allow cells to respond appropriately to estrogen and progesterone, supporting normal breast development and function during puberty, menstrual cycles, and pregnancy. These hormones travel through the bloodstream, and when they encounter breast cells with matching receptors, they bind to those receptors and trigger specific cellular responses. This is all part of normal, healthy physiology.

When breast cancer develops in cells that have retained these receptors, the same hormone-receptor interaction occurs, but now it drives abnormal cancer growth instead of normal breast function. The activated receptors in cancer cells cause changes in the expression of specific genes—essentially turning certain genes “on” or “off”—which can stimulate the cells to divide and multiply rapidly.^[2] This is how hormones that normally support healthy tissue end up fueling cancer progression.

Hormone receptor positive breast cancers tend to grow more slowly than hormone receptor negative cancers.^[3] This slower growth pattern is actually one reason why HR-positive cancers often have a better prognosis—there’s more time to detect them, and they respond well to hormone-blocking treatments that can keep them under control for many years.

The dependence on hormones also means that factors affecting hormone levels in the body—such as menopause, which dramatically reduces estrogen production, or treatments that block hormone production or action—can have profound effects on tumor growth. This biological dependence is both the mechanism of disease and the key to treatment.

Treatment Options and Their Importance

The good news about hormone receptor positive breast cancer is that it responds to treatments specifically designed to block the effects of hormones. Hormone therapy (also called hormonal therapy, hormone treatment, or endocrine therapy) slows or stops the growth of hormone-sensitive tumors by either blocking the body’s ability to produce hormones or by interfering with the effects of hormones on breast cancer cells.^[2]

Hormone therapy can be used in several ways throughout the course of treatment. It may be given before surgery to shrink a large tumor, making it easier to remove—this is called neoadjuvant hormone therapy. More commonly, it’s given after surgery and possibly other treatments to reduce the risk of the cancer coming back (recurrence)—this is called adjuvant hormone therapy. Hormone therapy can also be used to help stop advanced-stage cancer from growing, or even to reduce breast cancer risk in women who haven’t been diagnosed but have a much higher than average risk.^[3]

There are three main categories of hormone therapy medications. Aromatase inhibitors stop the body from making estrogen by blocking an enzyme called aromatase that converts other hormones into estrogen. These drugs are particularly useful in postmenopausal women. Selective estrogen receptor modulators (SERMs), like tamoxifen, block the action of estrogen on breast cancer cells by attaching to estrogen receptors and preventing estrogen from binding there. Selective estrogen receptor downregulators (SERDs) work similarly but also help eliminate the receptors themselves.^[11]

Doctors often recommend that patients take hormone therapy for 5 to 10 years, depending on the individual situation and risk of cancer recurrence.^[17] This long duration reflects the fact that hormone receptor positive breast cancer cells can remain dormant in the body for years before attempting to grow again. Continuing hormone therapy throughout this period provides ongoing protection by maintaining a low-hormone environment that makes it difficult for any remaining cancer cells to thrive.

Treatment for ER-positive breast cancer typically involves a combination approach. Healthcare providers may use breast cancer surgery to remove tumors, radiation therapy, chemotherapy if needed, and hormone therapies like aromatase inhibitors to reduce estrogen in the body or SERMs to reduce the risk of recurrence.^[9] The specific combination depends on factors like the stage of cancer, how aggressive it is, whether it has spread to lymph nodes, and the patient’s overall health.

Living with Treatment Side Effects

While hormone therapy is highly effective at preventing breast cancer recurrence, it can cause side effects that affect quality of life. Understanding these side effects and knowing that most can be managed helps patients stay on treatment for the full recommended duration, which is crucial for the best outcomes.

Common side effects of hormone therapy include hot flashes, which are sudden feelings of warmth that can be quite uncomfortable. Bone, joint, or muscle stiffness and pain—sometimes called arthralgias—can make movement difficult. Vaginal dryness can affect comfort and intimacy. Some people experience brain fog, a feeling of mental cloudiness or difficulty concentrating. In younger women who are still premenopausal, hormone therapy can cause bone thinning.^[17]

It’s important to note that side effects vary widely from person to person. Some people rarely experience them, while others find the side effects significantly disturb their quality of life. The severity and type of side effects can also depend on which specific hormone therapy medication you’re taking—for example, aromatase inhibitors and SERMs like tamoxifen can have somewhat different side effect profiles.

Fortunately, there are many ways to manage these side effects. Medications can help—for instance, drugs normally used to treat anxiety or depression (SSRIs) can also reduce hot flashes, though it’s important to discuss both the benefits and risks of these medications with your oncologist. For bone loss, drugs called bisphosphonates can strengthen bones and reduce the risk of osteoporosis. For vaginal dryness and sexual side effects, lubricants and, in some cases, topical estrogens may provide relief. Recent data show no evidence that topical estrogens used by women with HR-positive breast cancer increase the risk of breast cancer death, but this should be thoroughly discussed with your doctor.^[17]

Lifestyle modifications play a vital role in managing side effects. Exercise helps with fatigue, mood, joint pain, and many other symptoms. Mind-body approaches like mindfulness meditation, deep breathing exercises, and yoga can alleviate anxiety, depression, and stress. Acupuncture has been shown to help with hot flashes, joint pain, and neuropathy (tingling or numbness in hands and feet that can result from chemotherapy).^[17]

Many cancer centers offer integrative oncology programs that provide resources like group therapy, behavioral therapy, mindfulness training, yoga classes, and acupuncture—often free of charge for patients. Taking advantage of these resources can make a significant difference in how you feel throughout treatment. The emotional support from connecting with other people going through similar experiences is also invaluable.